{"classes":[{"title":"Largest spinal collapse volume"},{"title":"Total spinal collapse volume"}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}],"units":"Participants"}],"description":"* This was intended as a novel end-point produced by OCMR scientists, in which high-resolution 3D imaging of the spine and pelvis are analysed for the extent of vertebral collapse.\n* Unfortunately, we were unable to collect data for the total spinal hole volume and total spine collapse volume at the point of novel magnetic resonance (MR) scan, due to technical challenges.","groups":[{"description":"Group 1a: New Myeloma; Group 1b: Relapsed Myeloma Group;1c: Smouldering Myeloma\n\nBaseline AND Follow-Up Assessment:\n\nNovel MR Whole body DXA scan Blood and urine samples QOL \\& scan experience questionnaires","id":"OG000","title":"Group 1- Myeloma"},{"description":"Baseline AND Follow-Up Assessment:\n\nNovel MR Whole body DXA scan Blood and urine samples QOL \\& scan experience questionnaires","id":"OG001","title":"Group 2- MGUS"},{"description":"Baseline Assessment ONLY:\n\n* Novel MR\n* QOL \\& scan experience questionnaires","id":"OG002","title":"Group 3- Healthy Volunteers"}],"populationDescription":"\\- Unfortunately, we were unable to collect data for the total spinal hole volume and total spine collapse volume at the point of novel MR scan, due to technical challenges.","reportingStatus":"POSTED","timeFrame":"At baseline","title":"Primary Outcome 1+2: Quantifying Tumour Burden (Total Spinal 'Collapse' Volume)","type":"PRIMARY"}